Evolution and structure of clinically relevant gene fusions in multiple myeloma
Multiple myeloma is characterised by frequent gene fusions. Here, the authors use data from the Multiple Myeloma Research Foundation CoMMpass Study to further investigate fusion genes in this disease and their clinical relevance.
Guardado en:
Autores principales: | Steven M. Foltz, Qingsong Gao, Christopher J. Yoon, Hua Sun, Lijun Yao, Yize Li, Reyka G. Jayasinghe, Song Cao, Justin King, Daniel R. Kohnen, Mark A. Fiala, Li Ding, Ravi Vij |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2a4adbc95da54e6daefbf479c5c03fa9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Co-evolution of tumor and immune cells during progression of multiple myeloma
por: Ruiyang Liu, et al.
Publicado: (2021) -
Expressed fusion gene landscape and its impact in multiple myeloma
por: A. Cleynen, et al.
Publicado: (2017) -
A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma
por: Kinan Alhallak, et al.
Publicado: (2021) -
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma
por: Cinzia Federico, et al.
Publicado: (2020) -
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma
por: Katia Todoerti, et al.
Publicado: (2021)